发明授权
- 专利标题: SAB as a biomarker for degenerative diseases and therapeutic sensitivity in cancers
-
申请号: US15828842申请日: 2017-12-01
-
公开(公告)号: US10078090B2公开(公告)日: 2018-09-18
- 发明人: Jeremy W. Chambers
- 申请人: Jeremy W. Chambers
- 申请人地址: US FL Miami
- 专利权人: The Florida International University Board of Trustees
- 当前专利权人: The Florida International University Board of Trustees
- 当前专利权人地址: US FL Miami
- 代理机构: Saliwanchik, Lloyd & Eisenschenk
- 主分类号: G01N33/68
- IPC分类号: G01N33/68 ; G01N33/574 ; A61K31/337 ; A61K31/519 ; A61K31/69 ; A61K31/167 ; A61K31/5377 ; C12Q1/6883 ; A61K38/07 ; C07K16/28 ; G01N33/50 ; C12Q1/6886 ; C07K16/18
摘要:
The current invention pertains to a method of diagnosing a disease or identifying an increased likelihood of developing the disease in a subject. The method comprises determining the level of Src homology 3 domain binding protein 5 (SH3BP5 or SAB) or the RNA encoding SAB protein in a biological sample obtained from the subject and identifying the subject as having the disease or having an increased likelihood of developing the disease if the biological sample obtained from the subject has an altered level of SAB protein or the RNA encoding SAB protein relative to a control sample. The methods of the current invention can be practiced to diagnose and treat a systemic degenerative disease, a neurodegenerative disease, obesity, diabetes, a cancer, or an aging related disease. The invention also provides a kit for diagnosing a disease or diagnosing an increased likelihood of developing the disease in a subject.
公开/授权文献
信息查询
IPC分类: